Literature DB >> 21569379

Infective endocarditis caused by Arcanobacterium haemolyticum: a case report.

Vanessa Wong1, Tom Turmezei, Maria Cartmill, Shiu Soo.   

Abstract

Arcanobacterium haemolyticum is an organism that commonly causes pharyngitis and wound infections. It does not usually cause systemic invasive disease. The organism presents a difficult diagnostic problem because the Clinical Microbiology laboratory has a propensity to view them as diphtheroid organisms of the Corynebacterium species, thus contaminants or normal flora. We describe a case of a 21-year-old female who had endocarditis with cerebral emboli due to Arcanobacterium haemolyticum. This rare condition is associated with significant mortality and to the best of our knowledge; this is the first successfully treated case of A. haemolyticum endocarditis complicated by embolic phenomenon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569379      PMCID: PMC3103420          DOI: 10.1186/1476-0711-10-17

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


  16 in total

1.  Brain abscess due to Arcanobacterium haemolyticum after dental extraction.

Authors:  Jair Vargas; Marbelys Hernandez; Christian Silvestri; Orlando Jiménez; Napoleón Guevara; Martín Carballo; Novella Rojas; Jorge Riera; Ernesto Alayo; Maria Fernández; Alfonso J Rodriguez-Morales; Marisela Silva
Journal:  Clin Infect Dis       Date:  2006-06-15       Impact factor: 9.079

2.  Arcanobacterium haemolyticum associated with pyothorax: case report.

Authors:  Subhash Chandra Parija; Venkatesh Kaliaperumal; Saka Vinod Kumar; Sistla Sujatha; Venkateshwara Babu; V Balu
Journal:  BMC Infect Dis       Date:  2005-09-06       Impact factor: 3.090

3.  Antimicrobial susceptibility of Arcanobacterium haemolyticum.

Authors:  P Carlson; S Kontiainen; O V Renkonen
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

4.  Corynebacterium hemolyticum endocarditis on a native valve.

Authors:  M G Worthington; B D Daly; F E Smith
Journal:  South Med J       Date:  1985-10       Impact factor: 0.954

5.  Effects of media, atmosphere, and incubation time on colonial morphology of Arcanobacterium haemolyticum.

Authors:  L A Cummings; W K Wu; A M Larson; S E Gavin; J S Fine; M B Coyle
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

6.  Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov.

Authors:  M D Collins; D Jones; G M Schofield
Journal:  J Gen Microbiol       Date:  1982-06

7.  Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa.

Authors:  A Mackenzie; L A Fuite; F T Chan; J King; U Allen; N MacDonald; F Diaz-Mitoma
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

8.  Biotypes of Arcanobacterium haemolyticum.

Authors:  P Carlson; K Lounatmaa; S Kontiainen
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Endocarditis caused by Arcanobacterium haemolyticum.

Authors:  J I Alós; C Barros; J L Gómez-Garcés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

Review 10.  Systemic and deep-seated infections caused by Arcanobacterium haemolyticum.

Authors:  R L Skov; A K Sanden; V H Danchell; K Robertsen; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 5.103

View more
  2 in total

Review 1.  Clinically Infrequent Arcanobacterium haemolyticum Bacteremia Complicated by Foot Decubitus Ulcer: An Educational Reminder for Primary Care Physicians.

Authors:  Noriko Takamura; Katsushige Tada; Haruhiko Ishioka; Harumi Gomi
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

2.  Smooth and Rough Biotypes of Arcanobacterium haemolyticum Can Be Genetically Distinguished at the Arcanolysin Locus.

Authors:  Haley S Ruther; Kalyn Phillips; Dolores Ross; Alyssa Crawford; M Payton Weidner; Osama Sammra; Christoph Lämmler; David J McGee
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.